AMERICAN JOURNAL OF PSYCHIATRY

Scope & Guideline

Elevating Psychiatric Knowledge for Better Care

Introduction

Delve into the academic richness of AMERICAN JOURNAL OF PSYCHIATRY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0002-953x
PublisherAMER PSYCHIATRIC PUBLISHING, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1945 to 2024
AbbreviationAM J PSYCHIAT / Am. J. Psychiat.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024

Aims and Scopes

The American Journal of Psychiatry is dedicated to advancing the understanding and treatment of psychiatric disorders through rigorous research. The journal encompasses a wide range of topics that reflect the complexities of mental health, integrating clinical, neurobiological, genetic, and sociocultural perspectives.
  1. Clinical Research in Psychopharmacology:
    The journal publishes studies focusing on the efficacy and safety of pharmacological treatments for various psychiatric conditions, including depression, anxiety, and substance use disorders, emphasizing the need for evidence-based practices.
  2. Neurobiological and Genetic Investigations:
    Research exploring the neurobiological mechanisms underlying psychiatric disorders, including neuroimaging studies, genetic associations, and the role of inflammation and metabolic factors in mental health.
  3. Innovative Therapeutic Approaches:
    The journal highlights emerging treatments and interventions, such as neuromodulation techniques (e.g., rTMS, ketamine), psychotherapy advancements, and the integration of digital health technologies into psychiatric care.
  4. Socioenvironmental and Racial Disparities:
    Addressing the impact of social determinants on mental health, the journal publishes research examining racial and ethnic disparities in psychiatric disorders, treatment access, and outcomes.
  5. Transdiagnostic Approaches:
    The journal supports research that transcends traditional diagnostic boundaries, focusing on shared mechanisms across disorders and the implications for treatment and prevention strategies.
The American Journal of Psychiatry is currently witnessing several emerging trends that reflect the dynamic nature of psychiatric research and clinical practice. These themes indicate a shift towards more personalized, integrative, and socially aware approaches to mental health.
  1. Precision Psychiatry:
    An increasing number of studies are focusing on precision medicine approaches, integrating genetic, neurobiological, and psychosocial factors to tailor treatments for individuals based on their unique profiles.
  2. Integration of Technology in Treatment:
    There is a growing trend towards utilizing digital health technologies and telehealth solutions, particularly in the context of the COVID-19 pandemic, enhancing access and engagement in mental health care.
  3. Focus on Inflammation and Mental Health:
    Emerging research is increasingly linking inflammation with psychiatric disorders, highlighting its role in the pathophysiology of conditions such as depression and anxiety, thus paving the way for novel therapeutic targets.
  4. Racial and Ethnic Disparities in Mental Health:
    An enhanced focus on understanding and addressing racial and ethnic disparities in mental health outcomes and access to care is becoming a vital area of research, reflecting broader societal concerns.
  5. Neurostimulation and Novel Therapeutics:
    The exploration of innovative therapeutic modalities, including neuromodulation techniques such as rTMS and the use of psychedelics for treatment-resistant conditions, is rapidly gaining traction in the literature.

Declining or Waning

While the American Journal of Psychiatry continues to evolve, certain themes have shown a decline in prominence over recent years. This may reflect shifts in clinical practice, research priorities, or emerging insights that have rendered previous topics less central.
  1. Traditional Psychotherapy Methods:
    Research focusing solely on traditional psychotherapy modalities without integration of newer approaches or understanding of neurobiological mechanisms appears to be declining, as the field moves towards more integrated and evidence-based practices.
  2. Generalized Studies on Substance Use Disorders:
    While substance use remains a critical area, the focus on generalized studies without specific insights into personalized treatment approaches or the neurobiological underpinnings is less prevalent.
  3. Longitudinal Studies Without Modern Analytical Techniques:
    Longitudinal studies that do not utilize advanced analytical methods or fail to incorporate modern genetic and neurobiological frameworks are becoming less common, as newer methodologies provide richer insights.
  4. Basic Science Without Clinical Relevance:
    Research that remains purely theoretical or basic science without clear clinical applications is receiving less emphasis, as the journal increasingly prioritizes studies with direct implications for clinical practice.

Similar Journals

EUROPEAN PSYCHIATRY

Pioneering Research in Psychiatry and Mental Health
Publisher: CAMBRIDGE UNIV PRESSISSN: 0924-9338Frequency: 1 issue/year

EUROPEAN PSYCHIATRY, published by Cambridge University Press, stands at the forefront of advancements in the field of psychiatry and mental health, serving as a vital resource for researchers, professionals, and students alike. With an impressive Q1 ranking in Psychiatry and Mental Health and an impact factor that underscores its significance, this journal fosters innovative studies and discussions that shape contemporary understanding of mental health issues. Offering Open Access since 2020, it ensures that high-quality research is readily available to a global audience, bridging gaps in knowledge dissemination. The journal, which has been publishing since 1991, encompasses a broad range of topics relevant to mental health, emphasizing evidence-based practices and interdisciplinary approaches to treatment and care. With its ongoing commitment to excellence, EUROPEAN PSYCHIATRY continues to be an indispensable platform for advancing the science of mental health.

HARVARD REVIEW OF PSYCHIATRY

Bridging research and practice in mental health.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1067-3229Frequency: 6 issues/year

HARVARD REVIEW OF PSYCHIATRY is a prestigious academic journal focused on the field of psychiatry and mental health, published by Lippincott Williams & Wilkins. Established in 1993, this journal has become a critical resource for researchers, clinicians, and students alike, providing cutting-edge insights and scholarly articles that address contemporary issues in mental health. With an impressive impact factor reflected in its Q1 ranking in Psychiatry and Mental Health, the journal ranks #90 out of 567 in its category in Scopus, placing it in the top 16% of publications in this field. The journal is dedicated to disseminating high-quality research and fostering dialogue among professionals, thus contributing significantly to the advancement of psychiatric sciences. Researchers can access the journal through traditional subscriptions, ensuring that vital knowledge and innovative practices are shared among a global audience.

Annals of Clinical Psychiatry

Exploring the Depths of Psychiatric Knowledge.
Publisher: QUADRANT HEALTHCOM INCISSN: 1040-1237Frequency: 4 issues/year

Annals of Clinical Psychiatry, published by QUADRANT HEALTHCOM INC, is a leading journal in the fields of Medicine and Psychiatry & Mental Health. With its longstanding commitment to advancing clinical knowledge since 1989, this esteemed journal contributes invaluable insights into current psychiatric practices and mental health research. The journal is recognized in the Scopus ranking with a position in the 34th percentile, reflective of its focused scope and substantial academic contributions. While access to the journal is tailored for professionals and researchers, the absence of Open Access highlights the journal's dedication to maintaining quality and rigorous peer-reviewed standards. As part of the Q3 quartile for both Medicine and Psychiatry categories in 2023, Annals of Clinical Psychiatry serves as an essential resource for those dedicated to improving mental health outcomes, making it a vital platform for practitioners, researchers, and students alike. Situated in Parsippany, New Jersey, the journal remains a pivotal entity that fosters scholarly dialogue and exploration in clinical psychiatry.

PSYCHIATRY RESEARCH

Empowering minds through rigorous research.
Publisher: ELSEVIER IRELAND LTDISSN: 0165-1781Frequency: 12 issues/year

PSYCHIATRY RESEARCH is a leading journal published by Elsevier Ireland Ltd, dedicated to advancing the field of psychiatry and mental health through the dissemination of rigorous research. With an impressive impact factor and categorized in the top quartile (Q1) of both Biological Psychiatry and Psychiatry and Mental Health in 2023, this journal ranks 14th in the field of Medicine _ Psychiatry and Mental Health out of 567 journals, and 4th in Neuroscience _ Biological Psychiatry out of 51, showcasing its influence and quality. Since its inception in 1979, PSYCHIATRY RESEARCH has provided a platform for innovative studies, clinical trials, and comprehensive reviews aimed at understanding the complexities of mental health disorders. Although it operates under a traditional access model, the journal remains committed to making vital research available to the academic community, ensuring that both seasoned professionals and budding researchers have access to groundbreaking findings. Positioned as a hub for psychiatric research, it caters to a diverse audience including clinicians, psychologists, and students, empowering them to contribute to the evolving landscape of mental health care.

Asia-Pacific Psychiatry

Exploring Innovations in Psychiatry for a Healthier Tomorrow
Publisher: WILEYISSN: 1758-5864Frequency: 4 issues/year

Asia-Pacific Psychiatry is a leading academic journal published by WILEY, focused on the diverse and rapidly evolving fields of psychiatry and mental health within the Asia-Pacific region. With an ISSN of 1758-5864 and an E-ISSN of 1758-5872, this journal has been recognized for its significant impact, holding a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in Psychiatry and Mental Health as of 2023. Its commendable Scopus ranking places it at Rank #83 out of 567 in its category, highlighting its influence and relevance in contemporary research. The journal aims to facilitate the dissemination of high-quality research, reviews, and clinical insights that address mental health challenges, promote global understanding, and encourage collaboration among professionals and academics. Although it is not an open-access journal, the high impact factor underscores its value in the scholarly community, making it an essential resource for researchers, clinicians, and students dedicated to enhancing mental health practices and policies in the region and beyond.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Advancing the Frontiers of Neuropsychopharmacology
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0278-5846Frequency: 8 issues/year

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading peer-reviewed journal that serves the interdisciplinary field of neuropsychopharmacology and biological psychiatry. With an impressive impact factor in the first quartile of both Biological Psychiatry and Pharmacology categories, this journal provides a critical platform for the dissemination of cutting-edge research and innovative therapeutic approaches. Covering a broad range of topics from the molecular mechanisms underlying psychiatric disorders to advanced pharmacological interventions, it aims to foster scientific dialogue among researchers, clinicians, and students alike. The journal has been at the forefront of scientific inquiry since its inception in 1982 and continues to evolve, adapting to the ever-changing landscape of neuroscience and mental health research. With its focus on high-quality articles and a commitment to advancing the understanding of neuropsychopharmacology, this journal is essential for anyone interested in the complexities of brain function and mental health.

BMC Psychiatry

Fostering collaboration for innovative mental health solutions.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.

BJPsych Open

Innovative insights for contemporary psychiatric challenges.
Publisher: CAMBRIDGE UNIV PRESSISSN: 2056-4724Frequency: 6 issues/year

BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.

BJPsych Bulletin

Fostering Global Conversations on Psychiatry
Publisher: CAMBRIDGE UNIV PRESSISSN: 2056-4694Frequency: 6 issues/year

BJPsych Bulletin, published by Cambridge University Press, stands as a vital resource in the field of Psychiatry and Mental Health, offering open access articles since 2015 to foster widespread dissemination of knowledge. With an ISSN of 2056-4694 and an E-ISSN of 2056-4708, this journal has established an impactful presence, ranking in the Q2 category for Psychiatry and Mental Health in 2023 and placing within the 59th percentile among its peers according to Scopus, which ranks it #229 out of 567 in the category. Covering a diverse range of topics from clinical practices to psychiatric research, the BJPsych Bulletin encourages contributions that explore innovative ideas and discussions around mental health. Its critical role in advancing research and practice in the discipline is complemented by its accessibility to researchers, professionals, and students globally, ensuring that cutting-edge findings reach a broad audience and support the continuous evolution of mental health sciences.

Neuropsychopharmacology Reports

Bridging gaps in mental health research and treatment.
Publisher: WILEYISSN: Frequency: 4 issues/year

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.